Calcium Channel antagonist 3

CAS No. 687573-14-4

Calcium Channel antagonist 3( —— )

Catalog No. M37075 CAS No. 687573-14-4

Calcium Channel antagonist 3 is a voltage-gated calcium channel inhibitor (IC50 : 5-20 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 52 In Stock
25MG 84 In Stock
50MG 122 In Stock
100MG 178 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Calcium Channel antagonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    Calcium Channel antagonist 3 is a voltage-gated calcium channel inhibitor (IC50 : 5-20 μM).
  • Description
    Calcium Channel antagonist 3 (compound 397) is an inhibitor of voltage-gated calcium channels with an IC50 value of 5-20μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    687573-14-4
  • Formula Weight
    426.53
  • Molecular Formula
    C23H26N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C(OC1C(NCC3=CC=CC=C3)=O)=CC=C(S(=O)(=O)N4CC(C)CCC4)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Termin, Andreas P, et, al. Benzofuran, indole and benzothiophene sulfonamide calcium channel antagonists for treating pain. WO2006010008 A1 2006-01-26.
molnova catalog
related products
  • SERCA2a activator A

    SERCA2a activator A is a novel sarco/endoplasmic reticulum Ca2+-dependent ATPase 2a (SERCA2a) activator.

  • McN5691

    McN5691 (RWJ26240) is a voltage-dependent calcium channel blocker with antihypertensive activity that can be used in the study of diseases caused by vascular smooth muscle abnormalities.

  • Sipatrigine

    Sipatrigine (619C89) is an antiepileptic compound with neuroprotective activity through glutamate release, TREK ion channels, TRESK channels, sodium channels, and calcium channel inhibitors in the CNS, and can be used to study TRESK channels.